Endothelin-1 expression in scleroderma renal crisis

Human Pathology

Volumn 42, Issue 1, 2011, Pages 95-102

  Mouthon, Luc ^a   Mehrenberger, Marion ^a   Teixeira, Luis ^a   Fakhouri, Fadi ^a   Bérezné, Alice ^a   Guillevin, Loïc ^a   Noël, Laure Hélène ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Endothelin 1; Hemolytic and uremic syndrome; Histopathology; Scleroderma renal crisis; Systemic sclerosis

Indexed keywords

CYCLOSPORIN; ENDOTHELIN 1;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FIBRIN CLOT; GLOMERULUS CAPILLARY; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; JUXTAGLOMERULAR APPARATUS; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROSCLEROSIS; NEPHROTOXICITY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCLERODERMA; SCLERODERMA RENAL CRISIS; SYSTEMIC SCLEROSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE KIDNEY INJURY; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ENDOTHELIN-1; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VON WILLEBRAND FACTOR;

EID: 78649986422     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.018     Document Type: Article

References (32)

1. Tamby M.C., Chanseaud Y., Guillevin L., and Mouthon L. New insights into the pathogenesis of systemic sclerosis Autoimmun Rev 2 2003 152 157
2. Denton C.P., and Black C.M. Scleroderma-clinical and pathological advances Best Pract Res Clin Rheumatol 18 2004 271 290
3. Servettaz A., Agard C., Tamby M.C., Guilpain P., Guillevin L., and Mouthon L Systemic sclerosis: pathophysiology of a multifaceted disease Presse Med 35 12 Pt 2 2006 1903 1915 (Pubitemid 44915261)
4. Hachulla E., Clerson P., and Launay D. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study J Rheumatol 34 2007 2423 2430
5. Hachulla E., Gressin V., and Guillevin L. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum Nov 30 52 2005 3792 3800
6. Steen V.D. Scleroderma renal crisis Rheum Dis Clin North Am 29 2003 315 333
7. Teixeira L., Mahr A., Berezne A., Noel L.H., Guillevin L., and Mouthon L. Scleroderma renal crisis, still a life-threatening complication Ann N Y Acad Sci 1108 2007 249 258
8. Traub Y.M., Shapiro A.P., and Rodnan G.P. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases Medicine (Baltimore) 62 1983 335 352
9. Steen V.D., Costantino J.P., Shapiro A.P., and Medsger T.A. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors Ann Intern Med 113 1990 352 357
10. Steen V.D., and Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 2007 940 944
11. Penn H., Howie A.J., and Kingdon E.J. Scleroderma renal crisis: patient characteristics and long-term outcomes QJM 100 2007 485 494
12. Teixeira L., Mouthon L., and Mahr A. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients Ann Rheum Dis 67 2008 110 116
13. Steen V.D., and Medsger T.A. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis Arthr Rheum 41 1998 1613 1619
14. Steen V.D. Scleroderma renal crisis Rheum Dis Clin North Am 22 1996 861 878
15. Kahaleh M.B. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action Arthritis Rheum 34 1991 978 983
16. Vancheeswaran R., Magoulas T., and Efrat G. Circulating endothelin-1 levels in systemic sclerosis subsets-a marker of fibrosis or vascular dysfunction? J Rheumatol 21 1994 1838 1844
17. Kobayashi H., Nishimaki T., Kaise S., Suzuki T., Watanabe K., and Kasukawa R. Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis Clin Rheumatol 18 1999 425 427
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis Rheum 23 1980 581 590
19. LeRoy E.C., and Medsger T.A. Jr Criteria for the classification of early systemic sclerosis J Rheumatol 28 2001 1573 1576
20. Poormoghim H., Lucas M., Fertig N., and Medsger T.A. Jr Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients Arthritis Rheum 43 2000 444 451
21. Steen V.D. Clinical manifestations of systemic sclerosis Semin Cutan Med Surg 17 1998 48 54
22. Steen V.D., Mayes M.D., and Merkel P.A. Assessment of kidney involvement Clin Exp Rheumatol 21 3 Suppl 29 2003 S29 31
23. Racusen L.C., Solez K., and Colvin R.B. The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713 723
24. Danese C., Parlapiano C., and Zavattaro E. ET-1 plasma levels during cold stress test in sclerodermic patients Angiology 48 1997 965 968
25. Yamane K., Miyauchi T., and Suzuki N. Significance of plasma endothelin-1 levels in patients with systemic sclerosis J Rheumatol 19 1992 1566 1571
26. Kadono T., Kikuchi K., Sato S., Soma Y., Tamaki K., and Takehara K. Elevated plasma endothelin levels in systemic sclerosis Arch Dermatol Res 287 1995 439 442
27. Borcsok I., Schairer H.U., and Sommer U. Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene J Exp Med 188 1998 1563 1573
28. Arima S. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics Clin Exp Nephrol 7 2003 172 178
29. Kohan D.E. Endothelins in the normal and diseased kidney Am J Kidney Dis 29 1997 2 26
30. Lehrke I., Waldherr R., Ritz E., and Wagner J. Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria J Am Soc Nephrol 12 2001 2321 2329
31. Rohmeiss P., Birck R., Braun C., Kirchengast M., and van der Woude F.J. Targets for endothelin in the diseased kidney: clues for therapeutic intervention Exp Nephrol 7 1999 1 10
32. Dussaule J.C., Boffa J.J., Tharaux P.L., Fakhouri F., Ardaillou R., and Chatziantoniou C. Endothelin, renal diseases, and hypertension Adv Nephrol Necker Hosp 30 2000 281 303